PENNY BURKERT: Open Payments
NPI 1477565943 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 32 payments from 15 companies in 2025. Trend: 2023 $916 · 2024 $874 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $104 |
| Novo Nordisk Inc | 6 | $95 |
| Lilly USA, LLC | 4 | $76 |
| PFIZER INC. | 3 | $50 |
| Exact Sciences Corporation | 3 | $49 |
| AngioDynamics, Inc. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Ardelyx, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| Renalytix AI, Inc. | 1 | $20 |
Products named: TRELEGY ELLIPTA, Rybelsus, JARDIANCE, ELIQUIS, MOUNJARO, The Cologuard Plus Collection Kit, AURYON LASER SYSTEM 100-120 VAC, Ozempic.
Industry payments across AZ — which companies pay providers there.
